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Abstract
Background: Face-to-face cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) are both effective
treatments for depressive disorders, but access is limited. Online CBT interventions have demonstrated efficacy in decreasing
depressive symptoms and can facilitate the dissemination of therapies among the public. However, the efficacy of Internet-delivered
IPT is as yet unknown.
Objective: This study examines whether IPT is effective, noninferior to, and as feasible as CBT when delivered online to
spontaneous visitors of an online therapy website.
Methods: An automated, 3-arm, fully self-guided, online noninferiority trial compared 2 new treatments (IPT: n=620; CBT:
n=610) to an active control treatment (MoodGYM: n=613) over a 4-week period in the general population. Outcomes were
assessed using online self-report questionnaires, the Center for Epidemiological Studies Depression scale (CES-D) and the Client
Satisfaction Questionnaire (CSQ-8) completed immediately following treatment (posttest) and at 6-month follow-up.
Results: Completers analyses showed a significant reduction in depressive symptoms at posttest and follow-up for both CBT
and IPT, and were noninferior to MoodGYM. Within-group effect sizes were medium to large for all groups. There were no
differences in clinical significant change between the programs. Reliable change was shown at posttest and follow-up for all
programs, with consistently higher rates for CBT. Participants allocated to IPT showed significantly lower treatment satisfaction
compared to CBT and MoodGYM. There was a dropout rate of 1294/1843 (70%) at posttest, highest for MoodGYM.
Intention-to-treat analyses confirmed these findings.
Conclusions: Despite a high dropout rate and lower satisfaction scores, this study suggests that Internet-delivered self-guided
IPT is effective in reducing depressive symptoms, and may be noninferior to MoodGYM. The completion rates of IPT and CBT
were higher than MoodGYM, indicating some progress in refining Internet-based self-help. Internet-delivered treatment options
available for people suffering from depression now include IPT.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 69603913;
http://www.controlled-trials.com/ISRCTN69603913 (Archived by WebCite at http://www.webcitation.org/6FjMhmE1o)
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Introduction
Depression is a highly prevalent mental disorder [1] and it is
expected to rank as the leading cause of burden of disease in
high-income countries by 2030 [2]. Depression is associated
with serious disability [3], loss in quality of life [4], and
substantial economic costs both at an individual and a societal
level [5,6]. Both pharmacological and psychological treatments
for depressive disorders are effective in reducing symptoms [7].
Clinical practice guidelines recommend cognitive behavior
therapy (CBT) and interpersonal psychotherapy (IPT) as options
for psychological treatment [8-10]. CBT is based on the
cognitive theory that negative automatic thoughts, maladaptive
information processing, and avoidance behavior play a key role
in the development and maintenance of depression [11]. IPT
originates from interpersonal theory [12]. It links stressful life
events and insufficient social support to the development and
maintenance of depressive symptoms [13]. Both psychotherapies
are brief, highly structured, and can be manualized. CBT and
IPT have shown to be effective in reducing depression symptoms
compared to treatment as usual [7,14,15]. Meta-analyses show
that, when compared head-to-head, CBT and IPT do not differ
significantly from one another in their effectiveness [7,14,15].
Both CBT and IPT require significant therapist time. Long
waiting lists caused by low workforce numbers are common
[16]. Perceived social stigma, which hinders help seeking [17],
and high costs [18] may discourage individuals with a
psychiatric disorder from seeking professional help.
Internet-based self-help interventions offer potential solutions
to these barriers. Immediately accessible and less costly, online
interventions may offer a valuable alternative to face-to-face
therapy. Previous studies and meta-analyses have demonstrated
unguided Internet-based self-help interventions to be effective
for common mental disorders, with a pooled effect size of 0.28,
but dropout rates are high [8]. CBT programs have been
successfully delivered on the Internet [19,20]. However, to our
knowledge, no study has examined the effectiveness of
Internet-based IPT.
The present study examined the effectiveness of
Internet-delivered IPT and a new Internet-delivered CBT module
(from e-couch [21]) compared to an online CBT intervention
(MoodGYM). MoodGYM was originally developed for youth,
but has known efficacy in reducing depressive symptoms in
adults [22-24]. The trial was designed within a noninferiority
framework. Noninferiority trials are used when there is clear
evidence of efficacy for an existing standard treatment, such
that it is ethically unacceptable to employ a placebo or inactive
control group [25] and when a new treatment is hypothesized
to have comparable, but not necessarily superior, effectiveness
to the established intervention [26]. We hypothesized that the
new Internet-delivered modules of IPT and CBT would be
noninferior to a CBT module (MoodGYM) in reducing
symptoms of depression and anxiety. We also predicted that
the Internet-delivered IPT module would be rated by its users
as being as feasible, acceptable, and satisfactory as MoodGYM.
Method
Participants and Procedure
This automated, 3-arm, fully self-guided, online noninferiority
trial compared 2 new treatments (IPT and CBT) to an active
control treatment (MoodGYM) for depressed individuals. The
Internet-delivered CBT and IPT interventions (from e-couch)
were developed at the Centre for Mental Health Research
(CMHR) at the Australian National University (ANU). The
e-couch program targets a range of conditions currently
(depression, generalized anxiety disorder, social anxiety
disorder) with other conditions to be added in the future. It also
provides modules for bereavement and loss, as well as divorce
and separation. It comprises a mental health literacy component
and psychotherapeutic components for each condition (eg, CBT,
IPT, applied relaxation, physical activity, and behavioral
activation for depression). This study compared the IPT and
CBT components with the 4-module version of MoodGYM.
To increase external validity, there was no specific promotion
for the trial. Spontaneous visitors from around the world who
registered on the e-couch Internet website [21] between October
2009 and October 2010 and who showed interest in participating
in the research trial (by clicking a “I want more information
about the trial” button), were given information about the study.
Those who provided both informed consent to participating in
the trial (by clicking on the “I agree” button on the webpage)
and an email address were then asked to complete an online
baseline screening survey. Individuals who were 18 years of
age or older and not currently receiving treatment for depression
by a mental health specialist were eligible for inclusion in the
study. Individuals with suicide intention, as measured with a
suicidal ideation screening item on the Web Screening
Questionnaire (WSQ) [27], or those who scored above 27 (95th
percentile or higher) on the Center for Epidemiological Studies
Depression scale (CES-D) at baseline, were immediately
provided with an information page containing advice about
obtaining appropriate professional help, including emergency
help. They could, however, continue to participate in the study.
Excluded were individuals who were health professionals
treating people with depression or anxiety, researchers reviewing
depression or anxiety sites, or students studying anxiety or
depression as part of a college or university course. Individuals
who did not meet the inclusion criteria were directed to the
public version of the e-couch program, which provides
interventions for depression, generalized anxiety disorder, and
social phobia. Individuals were not required to provide their
real names, but were asked to use a pseudonym instead. Ethical
approval for the study was provided by the Human Research
Ethics Committee of the ANU (protocol number 2008/269).
Participants were randomly assigned to MoodGYM, CBT, or
IPT, stratified by sex, age, and presenting depression symptom
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severity. The randomization schedule for participant allocation
to condition groups was prepared by using an automated system
built into the trial software, and randomization occurred
automatically. The allocation sequence was concealed from the
researchers. Participants randomized to the intervention groups
were aware of the allocated arm. Following randomization, an
automated email containing log-in details for the assigned
program was sent to each participant, at which point the
intervention could be accessed immediately.
Interventions
All programs were offered over 4 weeks. Users were required
to complete the modules in order. Participants were able to
revisit previous pages of the modules and scores of previous
assessments, but were not able to repeat the assessments. Each
week an automated email was sent to advise participants of the
availability of their new module. Participants were always
offered the option to pause and restart at their chosen time. See
Figures 1-3 for screenshots of the 3 programs.
Internet-Delivered Cognitive Behavioral Therapy (CBT
e-couch)
The Internet-delivered CBT intervention comprised 1 component
of the depression stream of e-couch [21] and is based on the
principles of CBT [11]. In addition to an explanation of the
rationale of CBT, the program consisted of 3 major modules:
identifying negative thoughts, tackling negative thoughts, and
undertaking behavioral activation (based on activity scheduling
developed by Lewinsohn [28]). The program contained 18
exercises and assessments in total, which were saved in a
personal workbook.
Internet-Delivered Interpersonal Psychotherapy (IPT
e-couch)
The Internet-delivered form of IPT comprised 1 component of
the depression stream of e-couch [21]. It consisted of 4 modules
(grief, role disputes, role transition, and interpersonal deficits)
and a personal workbook (containing 13 exercises and
assessments). The IPT program was based on the IPT clinician
manual of Weissman et al [13], with each of the 4 IPT areas
constructed to reflect the areas and topics relevant to each area.
Interactive exercises reflected the topics and questions described
in the Interpersonal Inventory. Participants did not choose IPT
areas, but could decide the order in which they were completed;
exercises within each of the IPT areas were not compulsory.
Internet-Delivered CBT (MoodGYM)
The online CBT package comprised a 4-module version of
MoodGYM [29] delivered over 4 weeks. The details of the
program are described elsewhere [30,31]. In this trial, a set of
4 of the CBT modules, a personal workbook (containing 22
exercises and assessments), and a feedback evaluation form
were used. The modules cover the identification of and
behavioral methods to overcome dysfunctional thinking,
assertiveness, and self-esteem training. Each module takes
approximately 20 to 40 minutes to complete [31]. The relaxation
module was removed from the program for this study to match
the time length of the other 2 programs. Previous research has
demonstrated that this component is not needed for efficacy
[31].
Measures
All questionnaires comprised online standard self-report
measures taken at baseline (pretest), immediately after the
intervention (posttest), and 6 months after the intervention
(follow-up). Measures of participant characteristics were
collected at baseline, symptoms measures were administered
at all 3 time points, and user satisfaction was collected at
posttest.
Participant Characteristics
The survey included questions concerning sociodemographic
characteristics (age, gender, country of origin, location, and
education level), previous history of depression, previous use
of treatments for depression, marital status, preference for
randomization condition, perceived need for treatment, and
current medication.
Primary Outcome Measures: Depressive Symptoms
Center for Epidemiological Studies Depression Scale
The 20-item self-report CES-D was used to assess depressive
symptoms (item score: 0-3; total score range: 0-60) [32]. The
Internet CES-D is reliable and valid with a cut-off score of 22
(sensitivity: 0.94; specificity: 0.62) [33]. The Cronbach alpha
in this study was .90. Because the CES-D was administered
online, a cut-off score of 22 is used in this study.
Secondary Outcomes: Satisfaction, User-Perceived
Benefits, and Adherence
Client Satisfaction Questionnaire
The Client Satisfaction Questionnaire (CSQ-8) assesses global
client satisfaction with treatments [34]. The 8-item self-report
questionnaire uses scale response options from 1 to 4, with total
score ranges from 8 to 32. Previous research has reported that
the CSQ-8 has high internal consistency [35] and was
comparable to the Cronbach alpha in this study (Cronbach
alpha=.90).
Treatment Preference
Preference for randomization condition was assessed by asking
the question “Do you have a preference to be in one of the
programs?” at baseline. Participants replied with no preference
or “yes, program 1, 2, 3.” These data were included in the
analyses (no preference, preference: match/no match).
Adherence
Adherence was measured in 2 ways for each individual: (1)
completion of posttest surveys (all groups), and (2) the number
of IPT, CBT, or MoodGYM modules completed.
Statistical Analysis
Noninferiority trials require the a priori specification of a
noninferiority margin. We used the confidence interval (CI)
approach [36] to define the noninferiority margin for this study.
The noninferiority margin of the primary outcome measure
CES-D was set at a lower-bound 95% CI pre-post within-group
effect size of 0.33, which was based on the lower-bound 95%
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CI margin of the pre-post within-group effect size of 0.56 (95%
CI 0.33-0.79) of MoodGYM [24]. To decrease the risk of type
1 error (false acceptance of an ineffective treatment), the
standard deviation (SD) of the pretest was used in calculating
the lower-bound 95% CI margin of the effect size of 0.56; this
yields a conservative estimate of benefit. For noninferiority
trials, the null is E-S≤-delta and the alternative hypotheses
(1-sided) is E-S>-delta, where E is the experimental treatment
and S is the standard treatment. Figure 4 shows the formula for
calculating the t test statistic when testing noninferiority (using
the formula of Mascha and Sessler [26]).
The null hypothesis is rejected to claim noninferiority of the
standard control treatment and the new treatment, if T is larger
than the value of T from a t distribution with nE–nS–2df at
1–alpha. The P value is the probability of observing a larger
value of Tl, if the null hypothesis (ie, inferiority) were true in
the population sampled from. For a P value less than alpha, we
reject the null hypothesis and conclude noninferiority [26]. As
this was a noninferiority trial, this criterion did not apply for
the upper bound of the CI. Using 1-beta=.90 and alpha=.05
(2-sided), we needed at least 150 participants in each condition
at posttest (a total sample of 450 participants) to reach sufficient
statistical power.
Data integrity (distribution, outliers, skewness, and kurtosis)
tests were conducted. Measures of skewness and kurtosis
indicated deviations from normality for baseline CES-D scores
because of some extreme responses. The Box-Cox model
omitting the pretest scores was fitted and the transformed data
were compared with the raw data using mixed model analyses.
For ease of interpretation of the test results, only raw data are
reported because the conclusions were the same. The baseline
characteristics of the 3 groups were compared by using 1-way
analysis of variance (ANOVA), and Kruskal-Wallis and
Mann-Whitney U tests for continuous measures and chi-square
(χ2) tests for categorical variables.
In noninferiority trials, intention-to-treat (ITT) analysis will
often increase the risk of falsely claiming noninferiority (type
I error) [37]. Non-ITT analyses are preferred as a protection
from ITTs increase of type I error risk [38]. Therefore, the
effects of the interventions were analyzed by using both ITT
analyses and per-protocol approaches as recommended for
noninferiority trials by Piaggio et al [38]. There is greater
confidence in results when the conclusions are consistent [38].To
conduct the per-protocol analysis, 2 groups were created: those
who returned the posttest and follow-up surveys (completers),
and those who completed half or more of the treatment modules
and returned the surveys (adherent completers). Linear mixed
models (LMM) were used for both types of analyses. Restricted
maximum likelihood estimation was used with an unstructured
covariance structure accommodation with participant effects.
The LMM gives unbiased estimates of ITT effect under the
assumption that data from participants who withdrew were
missing at random (MAR). Test time was treated as a categorical
variable because we were interested in the differences between
groups on each occasion of measurement.
Between-group and within-group effect sizes were calculated
according to Cohen’s d (standardized mean difference) [39].
Clinically meaningful changes on the CES-D were assessed
using the clinically significant change (CSC) formula (with a
CES-D score <22) and the reliable change index (RCI) [40].
The RCI reflects the degree of change that occurred beyond the
fluctuations of an imprecise measuring instrument, with values
greater than 1.96 representing statistically significant change
[41]. In the present study, pretest SD scores of the CES-D with
a reliability of 0.90 were used in the RCI formula. In addition,
analyses were also undertaken for the subsample of participants
who had symptoms severe enough to be considered clinical
cases at baseline (score ≥22 on the CES-D). Chi-square tests
and 1-way ANOVA tests with Bonferroni correction at posttest
were used to examine differences in treatment completers and
noncompleters (those who completed less than half of the
modules). Statistical analyses were conducted using SPSS
version 19.0, except for the Box-Cox transformation procedures,
which were conducted using Stata 9.
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Figure 1. Screenshot of e-couch cognitive behavior therapy (CBT) website.
Figure 2. Screenshot of e-couch interpersonal psychotherapy (IPT) website.
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Figure 3. Screenshot of MoodGYM website.
Figure 4. Formula of Mascha and Sessler.
Results
Participants
Of the 10,598 individuals who registered on e-couch during the
trial period, 5796 expressed interest in the trial and proceeded
to screening. Of these, 3166 did not meet the eligibility criteria
(eg, under 18 years of age or currently receiving treatment for
depression by a mental health specialist) and were excluded
from the study. Of the remaining 2630 participants, 2045
provided informed consent; however, 116 of these did not
subsequently verify their email address. Accordingly, a total of
1929 participants were randomized to 1 of the 3 conditions.
However, 66 of these participants were excluded after
randomization because it became apparent that they were
ineligible at baseline for participation (eg, being a researcher
or a student, n=21). In addition, 45 randomized participants did
not complete the baseline assessment. This was missed at first
screening because of a technical fault, but was picked up
subsequently. Figure 5 shows the flowchart of participants
(CONSORT-EHEALTH checklist [42] presented in Multimedia
Appendix 1).
Of the total sample (N=1843), 543 (29.46%) were aged between
25 to 29 years, and most were female, (1334/1843, 72.38%).
Participants were primarily Australian or New Zealand residents
(751/1843, 40.75%) and most were well educated, having
completed postsecondary education (1606/1843, 87.14%). The
mean CES-D baseline score was 36 (SD 11.52). There were no
significant differences between the groups at baseline with
respect to depressive symptoms (χ22= 3.1, P=.21), demographic
characteristics (see Table 1), or treatment preference before
randomization (P=.73).
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Treatment Adherence and Attrition
In total, 30% (549/1843) of participants completed the posttest
assessment and 28% (336/1843) completed the follow-up
assessment. Of participants who were adherent to the program
(completed 50% or more of the modules), 25.8% (476/1843)
and 16% (294/1843) completed posttest and follow-up
assessments, respectively. Of the IPT participants, 49.5%
(307/620) completed at least half of the intervention (≥2
modules) and 27.3% (169/620) completed all modules. For the
CBT participants, 37.7% (230/610) finished 2 or more modules
and 14.4% (88/610) completed all modules. A total of 195 of
613 participants (31.8%) finished half or more of the MoodGYM
program. Of these, 10.9% (67/613) finished the whole program.
Reasons given for dropout included technical problems, personal
issues (lack of time), disease-specific barriers (feeling too
depressed to work on the program or not convinced that the
program would help), general intervention problems (programs
was taking too long, too much text to read, boring, or too
repetitive), specific intervention issues (the examples were not
relevant to the participant), or engagement issues (preferred to
obtain help from somewhere other than a computer). However,
most participants (1248/1294, 96%) did not provide any reason
for dropout. Those who dropped out of treatment had
significantly higher scores on the CES-D (χ21=4.3, P=.04), but
differences were small (mean difference 1.26). Furthermore,
dropout rates were significantly higher for participants assigned
to MoodGYM (451/613, 74%) compared with IPT (414/620,
67%) or CBT (429/610, 70%; χ22= 6.8, P=.03). Those who
dropped out of treatment were more likely to be female
(914/1294, 71%; χ21= 6.6, P=.01), and under 50 years of age
(1090/1294, 84%; χ21=21.6, P<.001). No significant differences
were found for medication use (P=.73), treatment preference
(P=.14), or marital status (P=.60).
Effectiveness and Noninferiority
Results are presented for 3 groups: all participants (all those
enrolled in the trial, ITT), completers (those completing online
surveys at posttest and at 6-month follow-up), and adherent
completers (those completing ≥50% of the modules).
For completers, the within-group effect sizes on the primary
outcome measure CES-D were large for all treatments at posttest
(IPT d=0.76 vs CBT d=0.87) and follow-up (IPT d=1.02 vs
CBT d=1.44). Between-group effect sizes were small (posttest:
IPT vs MoodGYM d=0.14, 95% CI –0.06 to 0.35; CBT vs
MoodGYM d=0.05, 95% CI –0.17 to 0.26; follow-up: IPT vs
MoodGYM d=0.18, 95% CI –0.09 to 0.45; CBT vs MoodGYM
d=0.12, 95% CI –0.15 to 0.39). Within-group effect sizes for
adherent completers ranged from d=0.74 to d=0.90 at posttest
and d=1.02 to d=1.33 at follow-up. The between-group effect
size for IPT vs MoodGYM was higher (posttest: d=0.23, 95%
CI 0.0-0.46; follow-up: d=0.31, 95% CI 0.02-0.60) than that
for CBT vs MoodGYM (posttest: d=0.02, 95% CI –0.25 to 0.22;
follow-up: d=0.04, 95% CI –0.26 to 0.34). The ITT analyses
yielded medium within-group effect sizes (d=0.59 to d=0.67 at
posttest and d=0.66 to d=0.80 at follow-up). Between-group
effect sizes were small (posttest: IPT vs MoodGYM d=0.09,
95% CI–0.02 to 0.21); CBT vs MoodGYM d=0.01, 95% CI
–0.10 to 0.12; follow-up: IPT vs MoodGYM d=0.09, 95% CI
–0.02 to 0.21; CBT vs MoodGYM d=0.03, 95% CI –0.08 to
0.14). See Table 2 and Multimedia Appendix 2.
The previously determined noninferiority margin (d=0.33) was
converted to delta=3.795 points differences on the CES-D (based
on a SD of 11.5). Using the formula of Mascha and Sessler [26],
a completers analysis indicated that IPT compared to
MoodGYM was found to be noninferior at posttest (t366=4.046,
P<.001, 95% CI –0.89 to 4.73). The mean difference between
IPT and MoodGYM on the CES-D for completers at posttest
was 1.92 points (95% CI –0.86 to 4.70, P=.17). MoodGYM
participants scored nonsignificantly lower at posttest. CBT
completers were also found to be noninferior to MoodGYM
(t341=2.142, P=.02; 95% CI –3.57 to 2.33), with a mean
difference at posttest of 0.62 points (lower for CBT) which was
not statistically significant (95% CI –2.30 to 3.54, P=.68). For
adherent completers, results were similar (IPT vs MoodGYM
posttest: t316=4.506, P<.001; CBT vs MoodGYM posttest:
t282=2.246, P<.001; 95% CI –3.39 to 2.91). There was a
nonsignificant mean difference between IPT and MoodGYM
on the CES-D for adherent completers at posttest of 3.05 which
was higher for IPT (95% CI 0.06-6.04, P=.05), but not for CBT
vs MoodGYM (mean difference: 0.24; 95% CI –2.88 to 3.36,
P=.88, lower for CBT). An ITT analysis also indicated that IPT
and CBT were found to be noninferior to MoodGYM (IPT:
t1231=4.769, P<.001, 95% CI –0.41 to 4.43; CBT: t1221=3.207,
P<.001, 95% CI –2.27 to 2.71). Mean depression scores were
not significantly different across the 3 programs at posttest (IPT
vs MoodGYM: 2.01, 95% CI –0.32 to 4.34, P=.09, higher for
IPT; CBT vs MoodGYM: 0.22, 95% CI: –2.17 to 2.61, P=.86,
higher for CBT).
Table 2 presents the means and SDs for completers, adherent
completers, and the ITT sample as produced by the LMM
procedure. Because LMM does not yield SDs, we calculated
them manually by using the formula SD=SEM×√N. For the
completers of posttest and/or follow-up, there was a significant
overall improvement over time for all groups on the CES-D
(F2,434.0=290.309, P<.001). There was no significant group×time
interaction effects on the CES-D at posttest (F4,436.3=1.15,
P=.33). Results were similar for the ITT sample and the adherent
completers (see Table 3).
Residuals of the models were inspected and showed
nonnormality. Therefore, to be thorough, power transforms were
estimated fitted using a Box-Cox model that included the same
terms as the mixed model omitting the pretest scores. The test
of deviations of residuals from normality was significant for
just the IPT group at posttest (t386.273=2.36, P=.02). We
compared the contrast results by using the transformed data to
the raw data, indicated that they have the same pattern of
significance. Because the normality violation was not profound
and because it is easier to interpret raw data (and
retransformation of model estimates is not always appropriate),
we have presented raw data in this paper.
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Table 1. Baseline demographic, socioeconomic, and clinical characteristics of participants for the e-couch cognitive behavioral therapy (CBT), the
e-couch interpersonal psychotherapy (IPT), and the MoodGYM website.
IPTCBTMoodGYMAll participantsCondition
620 (33.64)610 (33.10)613 (33.26)1843 (100)n/N (%)
451 (72.74)445 (72.95)438 (71.45)1334 (72.38)Female, n (%)
Age group (years), n (%)
115 (18.55)92 (15.08)100 (16.31)307 (16.66)18-24
174 (28.06)188 (30.82)181 (29.52)543 (29.46)25-34
161 (25.97)164 (26.88)145 (23.65)470 (25.50)35-44
114 (18.39)113 (18.52)111 (18.11)338 (18.34)45-55
56 (9.03)53 (8.69)76 (12.39)185 (10.04)>55
Country of residence, n (%)
258 (41.61)239 (39.18)254 (41.44)751 (40.75)Australia and New Zealand
149 (24.03)157 (25.73)148 (24.14)454 (24.63)United Kingdom
123 (19.84)115 (18.85)112 (18.27)350 (18.99)United States
36 (5.81)36 (5.90)28 (4.57)100 (5.43)Canada
54 (8.71)63 (10.32)71 (11.58)188 (10.20)Other
303 (48.87)310 (50.82)301 (49.10)914 (49.59)Spouse
Education
6 (0.97)4 (0.66)11 (1.79)21 (1.13)None, or primary
79 (12.74)67 (10.98)70 (11.42)216 (11.72)Secondary
535 (86.29)539 (88.36)532 (86.79)1606 (87.14)Postsecondary
36.38 (11.86)36.29 (11.04)35.34 (11.61)36.01 (11.52)Baseline CES-Da, mean (SD)
246 (39.68)255 (41.80)253 (41.27)754 (40.91)Current medicationb, n (%)
aCES-D: Center for Epidemiological Studies Depression scale.
bAny prescribed current medication.
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Figure 5. Flowchart of participants.
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Table 2. Results and effect sizes (Cohen’s d) for the Center for Epidemiological Studies Depression scale (CES-D) for completers and adherent
completers, and for intention-to-treat (ITT) analyses.
Between-group effect size, d (95% CI)Within-group effect size, d (95% CI)Test time, n; mean (SD)Program
Follow-up
(95% CI)PosttestProgramPre–follow-upaPre-postFollow-upPosttestPretest
Completers of posttest (n=549) and/or follow-up (n=336)
0.18
(–0.09,0.45)b
0.14
(–0.06,0.35)b
IPT vs
MoodGYM
1.02 (0.76,1.28)0.76 (0.56,0.96)129; 22.41
(13.84)
206; 26.22
(12.92)
206; 35.65
(11.85)
IPT
0.12
(–0.15,0.39)c
0.05
(–0.17,0.26)c
CBT vs
MoodGYM
1.44 (1.15,1.72)0.87 (0.65,1.0
9)
115; 18.17
(12.15)
181; 23.68
(13.34)
181; 34.46
(11.31)
CBT
1.04 (0.72,1.34)0.82 (0.59,1.04)92; 19.79
(14.92)
162; 24.30
(14.10)
162; 35.19
(12.44)
MoodGYM
Adherent completers of posttest (n=476) and/or follow-up (n=294)
0.31
(0.02,0.60)b
0.23
(0.0,0.46)b
IPT vs
MoodGYM
1.02 (0.74,1.28)0.74 (0.53,0.94)119; 22.50
(13.55)
192; 26.38
(13.25)
192; 35.60
(11.79)
IPT
0.04
(–0.26,0.34)c
0.02
(–0.25,0.22)c
CBT vs
MoodGYM
1.33 (1.02,1.63)0.89 (0.65,1.11)101; 17.75
(13.55)
158; 23.09
(13.25)
158; 34.30
(11.79)
CBT
1.21 (0.86,1.56)0.90 (0.64,1.16)74; 18.30
(13.55)
126; 23.33
(13.25)
126; 34.41
(11.32)
MoodGYM
ITT posttest and follow-up (N=1843)
0.09
(–0.02,0.21)b
0.09
(–0.02,0.21)b
IPT vs
MoodGYM
0.67 (0.55,0.78)0.59 (0.48,0.71)620; 23.17
(25.60)
620; 26.59
(20.27)
620; 36.38
(11.51)
IPT
0.03
(–0.08,0.14)c
0.01
(–0.10,0.12)b
CBT vs
MoodGYM
0.80 (0.69,0.92)0.67 (0.55,0.79)610; 19.68
(26.85)
610; 24.80
(21.34)
610; 36.29
(11.51)
CBT
0.66 (0.54,0.77)0.60 (0.49,0.72)613; 20.56
(29.69)
613; 24.58
(22.43)
613; 35.34
(11.52)
MoodGYM
aWithin-group follow-up effect size for completers is based upon the following pretest scores: IPT (n=129, mean 35.66, SD 12.05); CBT (n=115, mean
34.89, SD 11.05); MoodGYM (n=92, mean 34.13, SD 12.65); within-group follow-up effect size for adherent completers is based upon the following
pretest scores: IPT (n=119, mean 35.48, SD 11.91); CBT (n=101, mean 34.68, SD 11.90); MoodGYM (n=74, mean 33.77, SD 11.92).
bIn favor of MoodGYM.
cIn favor of CBT.
Table 3. Effectiveness of Internet-delivered programs with depression score (CES-D) as dependent variable.
Follow-upPosttestDepression score
Group×timeTimeGroup×timeTime
PF (df)PF (df)PF (df)PF (df)
Total sample
.311.20 (4,315.3)<.001237.187 (2,315.1).331.15 (4,436.3)<.001290.309 (2,434.0)Completers
.231.426 (4,284.5)<.001216.083 (2,284.1).201.52 (4,388.3)<.001260.021 (2,386.7)Adherent com-
pleters
<.001.221.45 (4,483.246)<.001382.60 (2,484.155)Intention-to-treat
Clinical cases
.510.824 (4,242)<.001223.572 (2,242).42.976 (4,369.4)<.001306.190 (2,368.8)Completers
.381.056 (4,243.1)<.001230.990 (2,242.9).241.39 (4,328.3)<.001275.800 (2,327.7)Adherent com-
pleters
.420.976 (4,451.2)<.001306.190 (2,368.8)Intention-to-treat
J Med Internet Res 2013 | vol. 15 | iss. 5 | e82 | p.10http://www.jmir.org/2013/5/e82/
(page number not for citation purposes)
Donker et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Clinically Significant Change and Reliable Change
Index for Completers
For completers, no significant differences in CSC were found
between the 3 programs at posttest (χ22=1.78, Ρ=.41) and
follow-up (χ22=3.70, P=.16). The number of participants
showing CSC at posttest were n=61 for IPT, n=65 for CBT, and
n=52 for MoodGYM. For adherent completers, results were
similar. Using the formula of Jacobson and Truax [40] for RCI
(the degree of change that occurred beyond the fluctuations of
an imprecise measuring instrument) with a Cronbach alpha of
.90, all programs reached the RCI critical value of 1.96 at
posttest (IPT: 2.01; CBT: 2.41; MoodGYM: 2.21) and follow-up
(IPT: 2.78; CBT: 3.82; MoodGYM: 2.86). The RCI results were
similar for adherent completers at posttest (IPT: 1.97; CBT:
2.40; MoodGYM: 2.47) and follow-up (IPT: 2.76; CBT: 3.59;
MoodGYM: 3.28; see Table 4).
Clinical Cases
Analyses were also undertaken for the subsample of participants
who had symptoms severe enough to be considered clinical
cases at baseline. A CES-D value of ≥22 is considered to
indicate clinical caseness [31]. For the ITT sample scoring ≥22
on the CES-D, analyses showed a significant overall
improvement over time for all groups on the CES-D
(F2,368.8=306.190, P<.001). No differences between the
treatments over time were found on the CES-D (F4,451.2=0.976,
P=.42). Within-group effect sizes on the primary outcome
measure CES-D were small for all treatments at posttest (IPT
d=0.55; CBT and MoodGYM d=0.56) and medium at follow-up
(CBT d=0.65; MoodGYM d=0.61) except for IPT, which was
small (IPT d=0.58). The RCI was below the critical value of
1.96 at posttest for all programs. At follow-up, all programs
reached the critical value of 1.96 (IPT: 2.26; CBT: 2.51;
MoodGYM: 2.46). For completers and adherent completers
scoring ≥22 on the baseline CES-D, results were similar (see
Table 3). RCI for completers was above 1.96 for all programs
at posttest (IPT: 2.93; CBT: 3.26; MoodGYM: 3.47) and
follow-up (IPT: 3.84; CBT: 4.80; MoodGYM: 4.97). RCI for
adherent completers was above 1.96 for all programs at posttest
(IPT: 2.95; CBT: 3.40; MoodGYM: 3.57) and follow-up (IPT:
4.00; CBT: 4.93; MoodGYM: 4.77, see Multimedia Appendix
3).
Treatment Satisfaction
There was a significant difference between the 3 interventions
in treatment satisfaction scores at posttest for completers as
measured with the CSQ-8 (F2,535=18.75, P<.001). Post hoc
analyses using Tukey’s honestly significant difference (HSD)
test showed that participants randomized to IPT (n=201) had a
significantly lower total satisfaction score (mean 20.55, SD
4.80) compared to MoodGYM (n=158; mean 22.81, SD 4.58)
with a mean difference of 2.26 (SD 0.49, P<.001) and CBT
(n=179; mean 23.26, SD 4.47) with a mean difference of 2.71
(SD 0.48, P<.001).
Table 4. Proportion of participants reaching the criteria for clinically significant change (score <22) on the Center for Epidemiological Studies Depression
scale (CES-D).
Clinically significant changeBaseline caseness, n (%)Treatment condition
6-month follow-up
n (%)
Posttest
n (%)
Adherent completersdCompleterscAdherent completersbCompletersa
49 (48.0)54 (43.5)55 (32.7)61 (32.0)581 (95.2)IPT (n=610)
32 (36.0)63 (57.3)61 (43.6)65 (38.2)581 (93.7)CBT (n=620)
36 (59.0)42 (51.2)41 (39.4)52 (34.7)575 (93.8)MoodGYM (n=613)
aCompleters posttest IPT (n=194), CBT (n=170), MoodGYM (n=150).
bAdherent completers posttest IPT (n=168), CBT (n=140), MoodGYM (n=104).
cCompleters 6-month follow-up IPT (n=124), CBT (n=110), MoodGYM (n=82).
dAdherent completers IPT (n=102), CBT, MoodGYM (n=61).
Discussion
Principal Results: Noninferiority, Effectiveness, and
Efficacy
The present study is the first to show that Internet-delivered
IPT can be effective in the treatment of depressive symptoms
at posttest and at 6-month follow-up. Both the IPT and the CBT
online interventions employed in the trial showed significant
medium to large within-group effect sizes on the CES-D for
completers and adherent completers. For the ITT sample, effect
sizes were smaller, but still moderate in size. Of the clinical
cases, completers and adherent completers showed medium to
large effect sizes on posttest and follow-up ratings. We found
that IPT and CBT were noninferior compared to MoodGYM
for those who returned posttest, and between-group effect sizes
were small. Although recent MoodGYM studies report similar
effect sizes to our study, our conclusions need to be taken with
some caution given that the effect size found in this study
differed from the effect size from the initial study, and therefore
might hamper assay sensitivity. Furthermore, the new CBT
program reached consistently higher, but not significant, effect
sizes compared to the IPT and the standard MoodGYM program.
Overall, the between-group effect sizes were larger for IPT
versus MoodGYM compared to CBT versus MoodGYM.
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Comparison With Prior Work
Our findings of the equivalent effectiveness of CBT and IPT
are concordant with previous research on face-to-face
interventions [7]. The within-group effect size for completers
of MoodGYM found in our study was similar to that of 2
recently published studies of unguided MoodGYM [23,43], but
was considerably higher than the trial conducted by its
originators in 2004 [22,24]. To be able to draw reliable
conclusions of noninferiority, it is important to establish effect
sizes of similar size to prior trials. To minimize bias, it is
important to replicate the conditions under which the control
treatment was previously examined (eg, the same population
sample, outcome measures, assessment time points, and delivery
of treatment). MoodGYM is automated and has fidelity as an
intervention. We have no reason to assume that omission of the
MoodGYM relaxation module accounts for the difference in
the effect size found in this study, because removal did not
affect treatment effectiveness in a previous dismantling study
[31]. The most likely cause of the observed differences lies in
the different samples recruited. The present study recruited
participants directly from those visiting a self-help website,
whereas the original study consisted of a sample of participants
selected randomly from the Australian electoral roll. The present
sample had higher depression scores at baseline compared to
the original trial [22,24]. The difference in dropout rate (42%
in the original study vs 70% in our study) might also account
for the higher effect size we found for our completer analysis,
because the effect size in our ITT sample (MoodGYM d=0.66)
is more similar to the effect size of the completers in the
originators study (MoodGYM d=0.56) [22,24]. Lower dropout
rates in the original study may have arisen from the addition of
weekly phone calls by lay interviewers, which might be
considered as minimal contact therapy [44] and might affect
the dropout rate [45]. However, a recent study by Farrer et al
[23] found no significant difference in dropout between
participants receiving weekly telephone calls in addition to
MoodGYM and those receiving only self-guided MoodGYM.
This aside, we can conclude that Internet-delivered IPT is likely
to be an effective treatment for depressive symptoms, and
thereby offers people with depression another online treatment
option
The CSC rates in the current study were lower than those
reported in other online studies [46,47]. One explanation for
this finding might be that those studies incorporated guidance,
whereas this study was fully automated. Another explanation
might be that the baseline CES-D scores were higher in this
study than typically found in other studies [47]. Hence, the drop
in CES-D score required to achieve a score in the nonclinical
range (ie, a CSC) is more difficult to reach. Clinical cases of
the ITT samples showed no reliable change. However,
completers of clinical cases showed reliable change for all
programs at posttest and follow-up. CBT reached consistently
higher RCI rates. CBT might be superior to IPT and/or
MoodGYM. However, as we did not set our hypothesis a priori
to test noninferiority between IPT and CBT, or superiority
between CBT and the other programs, conclusions cannot be
drawn because of insufficient power.
Feasibility and Satisfaction
There was no significant difference in treatment preference at
baseline before randomization. This lack of preference for
treatment condition is important, because it suggests that a
disparity between the preferred and allocated conditions was
unlikely to negatively impact disproportionately on the findings.
However, treatment satisfaction ratings were significantly lower
for the IPT program compared with MoodGYM and CBT. One
explanation for these findings may be related to what people
were looking for in an online intervention. Also, although there
were no patient program preferences before randomization, it
is unknown how participants felt about being randomized to
IPT immediately postrandomization but before exposure to the
treatment. Online CBT is widely known, whereas fewer
individuals know about IPT. To the extent that the social
psychological literature has demonstrated that familiarity breeds
liking, it may be possible that differences in satisfaction in
treatment were driven in part by differences in familiarity with
each treatment. Another explanation may be that the IPT
program was too brief. Adherence to the treatment was
considerably lower than the original MoodGYM trial [22]. As
mentioned earlier, the influence of weekly telephone calls in
the original study might have influenced the dropout rate, as
might the source of participants from among spontaneous
visitors to a self-help website. Some studies of unguided
self-help have reported similar dropout rates [43,48,49], but
others have not [7,50]. Completion rates for the new IPT and
CBT programs were significantly higher than for MoodGYM.
This could suggest that the new programs are more acceptable,
particularly to adults. Within a noninferiority framework, this
finding is very important, because newer implementations of
e-therapy were at least as effective as MoodGYM, whereas
completion rates—a key problem in this field [51]—were higher.
However, MoodGYM is a well-known open-access program.
Some participants assigned to MoodGYM could have
undertaken the program previously, and if so may have been
less willing to finish the intervention.
Limitations
This study has several limitations. First, as mentioned
previously, the effect size found in this study differs from that
on which we based the noninferiority margin and power
calculation. Second, the noninferiority margin of the primary
outcome measure is usually based on the lower-bound CI of the
between-group effect size of the traditional treatment [36]. In
our case, this would be an effect size of 0.33 and a lower-bound
95% CI of 0.11 [24]. To reach sufficient statistical power to be
able to detect a significant difference, we would need at least
14,000 participants per condition. Therefore, we used an
alternative approach to calculate the lower-bound noninferiority
margin. Based on the study of Mackinnon et al [24] we used
the within-group effect size of 0.56 instead. This resulted in a
noninferiority margin of an effect size of 0.33, which is a 3.795
difference on the CES-D. Although this difference is still liberal,
an effect size of 0.30 is considered as the minimum for clinically
meaningful change [52]. Third, LMM is based on the MAR
assumption, while dropout rates were very high. It is widely
recognized that the MAR assumption is untestable. MAR
assumes that the pattern of missing data does not depend on the
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unobserved data. This is a substantially weaker assumption than
missing completely at random (MCAR), in which the data are
missing independent of values of the observed and unobserved
data. Therefore, LMM is the most robust of the methods for
analyzing the data.
Low adherence, however, could underestimate differences
between groups, and therefore increase the likelihood of finding
noninferiority. However, our completer analyses revealed no
statistical differences in effectiveness between the 3 programs.
Nevertheless, our conclusions need to be taken with caution
given the high dropout rates. One possible explanation of the
difference in attrition rates across the programs might be that
MoodGYM takes longer to complete compared with the other
programs, and lengthier programs might be associated with
greater attrition [31]. Although MoodGYM had the highest
dropout rate, dropout was high among all conditions, a finding
that is common for Internet interventions. High dropout rates
are likely with minimal exclusion criteria, unguided
interventions [44,45], and little or no financial commitment
[51]. However, a recent study by Hilvert-Bruce et al [53] showed
that noncompleters derive benefit before dropping out. Also,
there were significant baseline differences (CES-D score,
gender, age) between participants who completed the programs
and those who did not, which might indicate selection bias. The
ITT analyses demonstrated effects nevertheless. In addition, it
was unknown whether participants used other treatments during
the study. This could mask real differences between groups if
this use of additional treatments was more prevalent for 1 group
compared with the others. Because we did not measure
additional use of other treatments, we cannot rule this possibility
out entirely. Finally, in face-to-face IPT, one focus is chosen,
whereas in the Internet-delivered IPT, all modules were
undertaken by the participant.
Future research is needed to replicate IPT noninferiority
compared to CBT programs, to test whether the new CBT
program is superior to other programs, to examine whether
guided Internet-delivered IPT is as effective as face-to-face IPT,
to investigate methods to improve adherence, to investigate
whether IPT would also be effective outside of a randomized
controlled trial setting, and whether Internet-delivered IPT is
also effective in the treatment of other disorders, such as social
phobia or panic disorder. It is important that future research
investigates individual characteristics, such as recent life events,
that predict treatment response for IPT. There will also be value
in investigating whether a planned extended version of e-couch
IPT will yield higher satisfaction ratings.
Conclusions
Although a firm conclusion regarding the noninferiority of IPT
and the sustainability of results compared to CBT cannot be
drawn yet, we can conclude that Internet-delivered IPT is an
effective treatment for depressive symptoms, and thereby offers
those with depression another online treatment option. An
Internet-accessed IPT program could potentially be more
appealing to IPT-trained therapists than a CBT-based one,
perhaps making such clinicians more likely to recommend it to
their clients. In the United Kingdom, the first wave of the
Increasing Access to Psychological Therapies (IAPT) initiative
was CBT only, but recently it has been expanded to other
approaches, including IPT. Given that MoodGYM is already a
resource used within IAPT (mostly without support),
Internet-delivered IPT could well be a feasible option in
second-wave IAPT services. Furthermore, the new e-couch
CBT program was shown to be noninferior to the active
CBT-based control program and thus may provide an
open-access alternative to MoodGYM. Another important
finding is that the completion rates of the new treatments were
higher, indicating some progress in refining Internet-based
self-help.
 
Acknowledgments
This study was funded by the Faculty of Psychology and Education of the VU University, Amsterdam, and the Center for Mental
Health Research at The Australian National University. HC is supported by NHMRC Fellowship 525411. KG is supported by
an NHMRC Senior Research Fellowship No 525413. We wish to thank Ada Tam, Philip Batterham, Jos Twisk, Bob Forrester,
Filip Smit, and Lisanne Warmerdam for their helpful comments and participation in the project.
Conflicts of Interest
The interventions investigated in the current study were developed at the Centre for Mental Health Research, The Australian
National University. HC and KG are authors and developers of the MoodGYM and e-couch websites, but derive no personal or
financial benefit from their operation.
Multimedia Appendix 1
CONSORT-EHEALTH checklist V1.6.2 [42].
[PDF File (Adobe PDF File), 996KB - jmir_v15i5e82_app1.pdf ]
Multimedia Appendix 2
Mean depression scores over time for interpersonal psychotherapy (IPT), cognitive behavior therapy (CBT), and MoodGYM
(intention-to-treat, N=1843).
J Med Internet Res 2013 | vol. 15 | iss. 5 | e82 | p.13http://www.jmir.org/2013/5/e82/
(page number not for citation purposes)
Donker et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
[PDF File (Adobe PDF File), 11KB - jmir_v15i5e82_app2.pdf ]
Multimedia Appendix 3
Results and effect sizes (Cohen's d) for Center for Epidemiological Studies Depression scale (CES-D) per protocol and
intention-to-treat (ITT) analyses for clinical cases (≥22 on the CES-D).
[PDF File (Adobe PDF File), 48KB - jmir_v15i5e82_app3.pdf ]
References
1. Kruijshaar ME, Barendregt J, Vos T, de Graaf R, Spijker J, Andrews G. Lifetime prevalence estimates of major depression:
an indirect estimation method and a quantification of recall bias. Eur J Epidemiol 2005;20(1):103-111. [Medline: 15756910]
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006
Nov;3(11):e442 [FREE Full text] [doi: 10.1371/journal.pmed.0030442] [Medline: 17132052]
3. van Schaik DJ, van Marwijk HW, Beekman AT, de Haan M, van Dyck R. Interpersonal psychotherapy (IPT) for late-life
depression in general practice: uptake and satisfaction by patients, therapists and physicians. BMC Fam Pract 2007;8:52
[FREE Full text] [doi: 10.1186/1471-2296-8-52] [Medline: 17854480]
4. Cuijpers P, de Graaf R, van Dorsselaer S. Minor depression: risk profiles, functional disability, health care use and risk of
developing major depression. J Affect Disord 2004 Apr;79(1-3):71-79. [doi: 10.1016/S0165-0327(02)00348-8] [Medline:
15023482]
5. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of
DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry
1994 Jan;51(1):8-19. [Medline: 8279933]
6. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A. Costs of nine common mental disorders: implications
for curative and preventive psychiatry. J Ment Health Policy Econ 2006 Dec;9(4):193-200. [Medline: 17200596]
7. Cuijpers P, Andersson G, Donker T, van Straten A. Psychological treatment of depression: results of a series of meta-analyses.
Nord J Psychiatry 2011 Dec;65(6):354-364. [doi: 10.3109/08039488.2011.596570] [Medline: 21770842]
8. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.
Am J Psychiatry 2000 Apr;157(4 Suppl):1-45. [Medline: 10767867]
9. Ellis P, Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression.
Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry 2004
Jun;38(6):389-407. [doi: 10.1111/j.1440-1614.2004.01377.x] [Medline: 15209830]
10. National Institute for Clinical Excellence (NICE). Depression: management of depression in primary and secondary care
(amended). In: NICE Clinical Practice Guideline 23. London: NICE; 2007.
11. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford Press; 1979.
12. Klerman GL, Budman S, Berwick D, Weissman MM, Damico-White J, Demby A, et al. Efficacy of a brief psychosocial
intervention for symptoms of stress and distress among patients in primary care. Med Care 1987 Nov;25(11):1078-1088.
[Medline: 3695638]
13. Weissman MM, Markowitz JC, Klerman GL. Clinician's Quick Guide to Interpersonal Psychotherapy. New York: Oxford
University Press; 2007.
14. Cuijpers P, Geraedts AS, van Oppen P, Andersson G, Markowitz JC, van Straten A. Interpersonal psychotherapy for
depression: a meta-analysis. Am J Psychiatry 2011 Jun;168(6):581-592. [doi: 10.1176/appi.ajp.2010.10101411] [Medline:
21362740]
15. Jakobsen JC, Hansen JL, Simonsen S, Simonsen E, Gluud C. Effects of cognitive therapy versus interpersonal psychotherapy
in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial
sequential analyses. Psychol Med 2012 Jul;42(7):1343-1357. [doi: 10.1017/S0033291711002236] [Medline: 22051174]
16. Cameron PA, Thompson DR. Changing the health-care workforce. Int J Nurs Pract 2005 Feb;11(1):1-4. [doi:
10.1111/j.1440-172X.2005.00499.x] [Medline: 15610338]
17. Barney LJ, Griffiths KM, Jorm AF, Christensen H. Stigma about depression and its impact on help-seeking intentions. Aust
N Z J Psychiatry 2006 Jan;40(1):51-54. [doi: 10.1111/j.1440-1614.2006.01741.x] [Medline: 16403038]
18. Palmqvist B, Carlbring P, Andersson G. Internet-delivered treatments with or without therapist input: does the therapist
factor have implications for efficacy and cost? Expert Rev Pharmacoecon Outcomes Res 2007 Jun;7(3):291-297. [doi:
10.1586/14737167.7.3.291] [Medline: 20528315]
19. Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is
effective, acceptable and practical health care: a meta-analysis. PLoS One 2010;5(10):e13196 [FREE Full text] [doi:
10.1371/journal.pone.0013196] [Medline: 20967242]
20. Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for depression and anxiety disorders: a review
of randomised controlled trials. Med J Aust 2010 Jun 7;192(11 Suppl):S4-11. [Medline: 20528707]
21. e-couch. URL: https://www.ecouch.anu.edu.au/welcome [accessed 2013-01-22] [WebCite Cache ID 6DsCazg8z]
J Med Internet Res 2013 | vol. 15 | iss. 5 | e82 | p.14http://www.jmir.org/2013/5/e82/
(page number not for citation purposes)
Donker et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
22. Christensen H, Griffiths KM, Jorm AF. Delivering interventions for depression by using the internet: randomised controlled
trial. BMJ 2004 Jan 31;328(7434):265 [FREE Full text] [doi: 10.1136/bmj.37945.566632.EE] [Medline: 14742346]
23. Farrer L, Christensen H, Griffiths KM, Mackinnon A. Internet-based CBT for depression with and without telephone
tracking in a national helpline: randomised controlled trial. PLoS One 2011;6(11):e28099 [FREE Full text] [doi:
10.1371/journal.pone.0028099] [Medline: 22140514]
24. Mackinnon A, Griffiths KM, Christensen H. Comparative randomised trial of online cognitive-behavioural therapy and an
information website for depression: 12-month outcomes. Br J Psychiatry 2008 Feb;192(2):130-134 [FREE Full text] [doi:
10.1192/bjp.bp.106.032078] [Medline: 18245031]
25. Pocock SJ. The pros and cons of noninferiority trials. Fundam Clin Pharmacol 2003 Aug;17(4):483-490. [Medline: 12914552]
26. Mascha EJ, Sessler DI. Equivalence and noninferiority testing in regression models and repeated-measures designs. Anesth
Analg 2011 Mar;112(3):678-687 [FREE Full text] [doi: 10.1213/ANE.0b013e318206f872] [Medline: 21304155]
27. Donker T, van Straten A, Marks I, Cuijpers P. A brief Web-based screening questionnaire for common mental disorders:
development and validation. J Med Internet Res 2009;11(3):e19 [FREE Full text] [doi: 10.2196/jmir.1134] [Medline:
19632977]
28. Lewinsohn PM. The behavioral study and treatment of depression. In: Hersen M, Eisler RM, Miller PM, editors. Progress
in Behavioral Modification, 1st ed. New York: Academic; 1975:19-65.
29. MoodGYM. URL: https://moodgym.anu.edu.au/welcome [accessed 2013-01-22] [WebCite Cache ID 6DsCeWxBr]
30. Christensen H, Griffiths KM, Korten A. Web-based cognitive behavior therapy: analysis of site usage and changes in
depression and anxiety scores. J Med Internet Res 2002 Mar;4(1):e3 [FREE Full text] [doi: 10.2196/jmir.4.1.e3] [Medline:
11956035]
31. Christensen H, Griffiths KM, Mackinnon AJ, Brittliffe K. Online randomized controlled trial of brief and full cognitive
behaviour therapy for depression. Psychol Med 2006 Dec;36(12):1737-1746. [doi: 10.1017/S0033291706008695] [Medline:
16938144]
32. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas
1977;1(3):385-401.
33. Donker T, van Straten A, Marks I, Cuijpers P. Brief self-rated screening for depression on the Internet. J Affect Disord
2010 May;122(3):253-259. [doi: 10.1016/j.jad.2009.07.013] [Medline: 19679358]
34. Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service
evaluation questionnaire. Eval Program Plann 1983;6(3-4):299-313. [Medline: 10267258]
35. Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization
and psychotherapy outcome. Eval Program Plann 1982;5(3):233-237. [Medline: 10259963]
36. Hwang IK, Morikawa T. Design issues in noninferiority equivalence trials. Drug Inform J 1999;33:1205-1218 [FREE Full
text] [WebCite Cache]
37. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996 Jul
6;313(7048):36-39 [FREE Full text] [Medline: 8664772]
38. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, CONSORT Group. Reporting of noninferiority and equivalence
randomized trials: an extension of the CONSORT statement. JAMA 2006 Mar 8;295(10):1152-1160. [doi:
10.1001/jama.295.10.1152] [Medline: 16522836]
39. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: L Erlbaum Associates; 1988.
40. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.
J Consult Clin Psychol 1991 Feb;59(1):12-19. [Medline: 2002127]
41. McGlinchey JB, Atkins DC, Jacobson NS. Clinical significance methods: Which one to use and how useful are they?
Behavior Therapy 2002 Sep 2002;33(4):529-550. [doi: 10.1016/S0005-7894(02)80015-6]
42. Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of
Web-based and mobile health interventions. J Med Internet Res 2011;13(4):e126 [FREE Full text] [doi: 10.2196/jmir.1923]
[Medline: 22209829]
43. Lintvedt OK, Griffiths KM, Sørensen K, Østvik AR, Wang CE, Eisemann M, et al. Evaluating the effectiveness and efficacy
of unguided internet-based self-help intervention for the prevention of depression: a randomized controlled trial. Clin
Psychol Psychother 2013 Sep;20(1):10-27. [doi: 10.1002/cpp.770] [Medline: 21887811]
44. Newman MG, Erickson T, Przeworski A, Dzus E. Self-help and minimal-contact therapies for anxiety disorders: Is human
contact necessary for therapeutic efficacy? J Clin Psychol 2003 Mar;59(3):251-274. [doi: 10.1002/jclp.10128] [Medline:
12579544]
45. Andersson G. Using the Internet to provide cognitive behaviour therapy. Behav Res Ther 2009 Mar;47(3):175-180. [doi:
10.1016/j.brat.2009.01.010] [Medline: 19230862]
46. Hedman E, Andersson G, Ljótsson B, Andersson E, Rück C, Mörtberg E, et al. Internet-based cognitive behavior therapy
vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial. PLoS One
2011;6(3):e18001 [FREE Full text] [doi: 10.1371/journal.pone.0018001] [Medline: 21483704]
J Med Internet Res 2013 | vol. 15 | iss. 5 | e82 | p.15http://www.jmir.org/2013/5/e82/
(page number not for citation purposes)
Donker et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
47. Warmerdam L, van Straten A, Twisk J, Riper H, Cuijpers P. Internet-based treatment for adults with depressive symptoms:
randomized controlled trial. J Med Internet Res 2008;10(4):e44 [FREE Full text] [doi: 10.2196/jmir.1094] [Medline:
19033149]
48. de Graaf LE, Huibers MJ, Riper H, Gerhards SA, Arntz A. Use and acceptability of unsupported online computerized
cognitive behavioral therapy for depression and associations with clinical outcome. J Affect Disord 2009 Aug;116(3):227-231.
[doi: 10.1016/j.jad.2008.12.009] [Medline: 19167094]
49. Melville KM, Casey LM, Kavanagh DJ. Dropout from Internet-based treatment for psychological disorders. Br J Clin
Psychol 2010 Nov;49(Pt 4):455-471. [doi: 10.1348/014466509X472138] [Medline: 19799804]
50. Spek V, Cuijpers P, Nyklícek I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of
depression and anxiety: a meta-analysis. Psychol Med 2007 Mar;37(3):319-328. [doi: 10.1017/S0033291706008944]
[Medline: 17112400]
51. Eysenbach G. The law of attrition. J Med Internet Res 2005;7(1):e11 [FREE Full text] [doi: 10.2196/jmir.7.1.e11] [Medline:
15829473]
52. Wilson DB, Lipsey MW. The role of method in treatment effectiveness research: evidence from meta-analysis. Psychol
Methods 2001 Dec;6(4):413-429. [Medline: 11778681]
53. Hilvert-Bruce Z, Rossouw PJ, Wong N, Sunderland M, Andrews G. Adherence as a determinant of effectiveness of internet
cognitive behavioural therapy for anxiety and depressive disorders. Behav Res Ther 2012 Aug;50(7-8):463-468. [doi:
10.1016/j.brat.2012.04.001] [Medline: 22659155]
Abbreviations
ANU: The Australian National University
CBT: cognitive behavioral therapy
CES-D: Center for Epidemiological Studies Depression scale
CMHR: Centre for Mental Health Research
CSC: clinically significant change
CSQ-8: Client Satisfaction Questionnaire
IAPT: Increasing Access to Psychological Therapies
IPT: interpersonal psychotherapy
ITT: intention-to-treat
LMM: linear mixed model
MAR: missing at random
RCI: reliable change index
WSQ: Web Screening Questionnaire
Edited by G Eysenbach; submitted 11.08.12; peer-reviewed by L Palmili, H O'Mahen; comments to author 29.12.12; revised version
received 31.01.13; accepted 15.02.13; published 13.05.13
Please cite as:
Donker T, Bennett K, Bennett A, Mackinnon A, van Straten A, Cuijpers P, Christensen H, Griffiths KM
Internet-Delivered Interpersonal Psychotherapy Versus Internet-Delivered Cognitive Behavioral Therapy for Adults With Depressive
Symptoms: Randomized Controlled Noninferiority Trial
J Med Internet Res 2013;15(5):e82
URL: http://www.jmir.org/2013/5/e82/ 
doi:10.2196/jmir.2307
PMID:23669884
©Tara Donker, Kylie Bennett, Anthony Bennett, Andrew Mackinnon, Annemieke van Straten, Pim Cuijpers, Helen Christensen,
Kathleen M Griffiths. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 13.05.2013. This
is an open-access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic
information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be
included.
J Med Internet Res 2013 | vol. 15 | iss. 5 | e82 | p.16http://www.jmir.org/2013/5/e82/
(page number not for citation purposes)
Donker et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
